Lv1
40 积分 2024-02-18 加入
Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis
3个月前
已完结
Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: A study at a tertiary cancer center
3个月前
已关闭
The clinical evaluation of HER‐2 status: which test to use?
3个月前
已完结
Digital imaging correlation of immunohistochemistry and fluorescence in situ hybridization in breast carcinoma cases with HER2 genetic heterogeneity
5个月前
已完结
152 Reevaluation of HER2 Heterogeneous Expression in Breast Cancer by Using Multi-FFPE Blocks
5个月前
已完结
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
5个月前
已完结
Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
5个月前
已完结
[Pathological features and immune microenvironment in HER-2 intratumoral heterogeneous breast cancers]
8个月前
已完结
Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping
8个月前
已完结
Understanding the Spectrum of HER2 Status in Breast Cancer: From HER2-Positive to Ultra-Low HER2
8个月前
已完结
皖公网安备34019202002308
